These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. Pearson TC, Hamano K, Morris PJ, Wood KJ. Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480 [No Abstract] [Full Text] [Related]
7. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation. Isobe M, Ihara A. Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106 [No Abstract] [Full Text] [Related]
9. Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells. Yoshimura N, Lee CJ, Shiho O, Kita M, Imanishi J, Oka T. Transplant Proc; 1995 Feb; 27(1):390-1. PubMed ID: 7879033 [No Abstract] [Full Text] [Related]
16. Production and use of neutralizing monoclonal antibodies to rat interleukin-2. Hancock WW, Alberghini TV, Chen-Woan M. Transplant Proc; 1989 Feb; 21(1 Pt 1):994-6. PubMed ID: 2650305 [No Abstract] [Full Text] [Related]
17. Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival. Lussow AR, Fanget L, Gao L, Buelow R, Pouletty P. Transplant Proc; 1996 Apr; 28(2):571-2. PubMed ID: 8623277 [No Abstract] [Full Text] [Related]